Selecting antidepressant therapy for patients with major depression

American Journal of Pharmaceutical Education

Volumn 65, Issue 2, 2001, Pages 190-194

  Cates, Marshall ^a  

^a SAMFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040748895     PISSN: 00029459     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Preskorn, S.H., Outpatient Management of Depression: A Guide for the Practitioner, 2nd ed., Professional Communications, Inc., Caddo OK (1999) pp. 57-170.
2. Pies, R.W., Handbook of Essential Psychopharmacology, American Psychiatric Press, Inc., Washington DC (1998) pp. 1-112.
3. Aronson, S.C. and Ayres, V.E., "Depression: a treatment algorithm for the family physician," Hospital Physician, (July 2000), pp. 21-44.
4. Kando, J.C., Wells, B.G. and Hayes, P.E., "Depressive disorders," in Pharmacotherapy: A Pathophysiologic Approach, 4th ed., (edit., DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G. and Posey, L.M.), Appleton & Lange, Stamford CT (1999) pp. 1141-1160.
5. Stimmel, G.L., "Mood disorders," in Textbook of Therapeutics: Drug and Disease Management, 7th ed., (edit., Herfindal, E.T. and Gourley, D.R.), Lippincott Williams & Wilkins, Philadelphia PA (2000) pp. 1203-1216.
6. Perry, P.J., Alexander, B. and Liskow, B.I., Psychotropic Drug Handbook, 7th ed., American Psychiatric Press, Inc., Washington DC (1997) pp. 131-199.
7. Stahl, S.M., Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd ed., Cambridge University Press, Cambridge UK (2000) pp. 199-262.
8. Schatzberg, A.F., Cole, J.O. and DeBattista, C., Manual of Clinical Psychopharmacology, 3rd ed., American Psychiatric Press, Inc., Washington DC (1997) pp. 31-98.
9. Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S. and Shader, R.I., "Drug interactions with newer antidepressants: role of human cytochrome P450," J. Clin. Psychiatry, S9(suppl. 15), 19-27(1998).
10. Michalets, E.L., "Update: clinically significant cytochrome P-450 drug interactions," Pharmacotherapy, 18, 84-112(1998).
11. 2000 Red Book, Medical Economics Company, Montvale NJ (2000).